ASO Author Reflections: Low Genetic Testing Utilization Among Patients with Breast, Ovarian, Pancreatic, and Prostate Cancers

被引：0
作者：
Nina M. Clark
Meghan R. Flanagan
机构：
[1] University of Washington,Department of Surgery
[2] Fred Hutchinson Cancer Center,Division of Public Health Sciences
来源：
Annals of Surgical Oncology | 2023年 / 30卷 / 3期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1327 / 1328
页数：1
相关论文
共 10 条
  • [1] Childers CP(2017)National estimates of genetic testing in women with a history of breast or ovarian cancer J Clin Oncol. 35 3800-3806
  • [2] Childers KK(2022)The feasibility of implementing mainstream germline genetic testing in routine cancer care: a systematic review Cancers. 14 1059-undefined
  • [3] Maggard-Gibbons M(2022)Patient and clinician decision support to increase genetic counseling for hereditary breast and ovarian cancer syndrome in primary care: a cluster randomized clinical trial JAMA Netw Open. 5 undefined-undefined
  • [4] Macinko J(undefined)undefined undefined undefined undefined-undefined
  • [5] Bokkers K(undefined)undefined undefined undefined undefined-undefined
  • [6] Vlaming M(undefined)undefined undefined undefined undefined-undefined
  • [7] Engelhardt EG(undefined)undefined undefined undefined undefined-undefined
  • [8] Kukafka R(undefined)undefined undefined undefined undefined-undefined
  • [9] Pan S(undefined)undefined undefined undefined undefined-undefined
  • [10] Silverman T(undefined)undefined undefined undefined undefined-undefined
1